Search Results
Sep 08, 2026, 11:00 ET AMID POLITICAL AD BOMBARDMENT, SAUSAGE DECLARES ITS CANDIDACY… FOR DINNER
https://volunteer.hungerfreeamerica.org. For the first 100 "Sausage for Dinner" donors, Johnsonville will send a limited-edition campaign swag pack stocked with an apron, hat, oven mitt, buttons, and bumper stickers.While Sausage aims to reach dinner tables across the nation, the campaign trail begins in Grand Rapids, Michigan,
More news about: Johnsonville
Aug 17, 2026, 22:10 ET Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-mitt-arx-hhs-fulc-obtaining-fair-deals-for-their-shareholders-302853344.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 13, 2026, 07:30 ET Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
regardless of MMR status. Overall survival is a key secondary endpoint. The mITT population enrolled 236 patients. As of the data cut-off, 106 progression-free survival events as assessed by the investigator had been observed in the mITT population. In connection with the EC-042 trial, Karyopharm entered into
More news about: Karyopharm Therapeutics Inc.
Aug 10, 2026, 10:28 ET TICK SOLUTIONS GLOBAL INTRODUCES TiCK TEST, A RAPID AT-HOME TICK DIAGNOSTIC THAT DELIVERS RESULTS IN 10 MINUTES
backed by science.Its flagship product, TiCK MiTT, was recognized as one of TIME's Best Inventions of 2025 and is available through national retailers including Petco, Costco, Bass Pro Shops and more than 3,500 retail locations nationwide. TiCK MiTT was also featured on Season 16 of Shark Tank.For
More news about: Tick Solutions Global
Aug 10, 2026, 05:06 ET Little Tikes Introduces Sweet Spaces, a Sweet New Take on Imaginative Role Play
adventures.Espresso Machine features a pretend steam function, perfect for café style play and endless make-believe moments.Apron & Oven Mitt Set lets little chefs suit up in style.Tea Set, perfect for hosting charming pretend tea parties and creative play.Pots
More news about: MGA Entertainment
Aug 05, 2026, 06:59 ET Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Tool ("SALT") score from baseline of 35.3% in the prespecified modified intent-to-treat ("mITT") analysis. Additionally, 40.0% of patients achieved a SALT-20 (80% of scalp hair coverage) response at Week 36 in the mITT analysis and 30.3% of patients achieved a SALT-20 response at Week 36 in the intent-to-treat
More news about: Q32 Bio
Aug 04, 2026, 09:00 ET Dionis Goat Milk Skincare Introduces Dionis Baby, Bringing Its Trusted Goat Milk Skincare Expertise to the Next Generation
the launch of Travel Sets, perfectly portioned for diaper bags and families on the go, along with Baby Bundles, and a signature Billy the Goat Wash Mitt and Lovey. The expansion also includes an exclusive limited-edition collaboration with award-winning baby essentials brand Mama Cocoa. Available exclusively
More news about: Dionis Goat Milk Skincare
Aug 04, 2026, 08:43 ET Wildfire Smoke Is Damaging Cars Thousands of Miles from the Flames, Auto Care Expert Warns
paint when rubbed across the surface. Instead, rinse the vehicle thoroughly with water before washing it, using proper automotive soap and a microfiber mitt.Protect your paint with a ceramic coating or paint sealant.A protective barrier helps reduce direct
More news about: Ziebart
Aug 03, 2026, 08:00 ET FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection
IBZ-ASPIRE trial is of non-inferiority design with the primary efficacy analysis in the Modified Intent-To-Treat (mITT) population. This will result in approximately 550 subjects in the mITT population, randomized in a 1:1 ratio to either ibezapolstat or standard-of-care vancomycin. The Agency also agreed
More news about: Acurx Pharmaceuticals, Inc.
Jul 31, 2026, 10:00 ET BRUCE BOLT CELEBRATES MAX CLARK'S MAJOR LEAGUE DEBUT WITH THE LAUNCH OF HIS CO-DESIGNED BATTING GLOVE AND PROTECTIVE GEAR
$95Long Cuff - Youth: $95Long Cuff - Adult: $105Protective GearLeg Guard: $90Elbow Guard: $70Speed Sliding Mitt: $70BRUCE BOLT transformed the batting glove from an overlooked accessory into essential performance equipment, combining obsessive craftsmanship,
More news about: BRUCE BOLT, LLC
Jul 30, 2026, 16:05 ET Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
regardless of MMR status. Overall survival is a key secondary endpoint. The mITT population enrolled 236 patients. As of the data cut-off, 106 progression free survival events as assessed by the investigator had been observed in the mITT population. In connection with the EC-042 trial, Karyopharm entered into a
More news about: Karyopharm Therapeutics Inc.
Jul 16, 2026, 10:07 ET TiCK MiTT Expands into Costco with Exclusive Value-Priced Two-Pack Across Select U.S. Markets
/PRNewswire/ -- TiCK MiTT by Tick Solutions Global today announced that its reusable, chemical-free tick detection and removal tool is now available in an exclusive value-priced two-pack at participating Costco warehouse locations across 16 states. The new retail partnership expands access to TiCK MiTT at a time
More news about: TiCK MiTT
Jul 14, 2026, 08:00 ET Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection
potential effect on reduction of CDI recurrence in the target population. The primary efficacy analysis will be performed using a Modified Intent-To-Treat (mITT) population.About the Ibezapolstat Phase 2 Clinical TrialThe completed multicenter, open-label single-arm segment (Phase 2a)
More news about: Acurx Pharmaceuticals, Inc.
Jul 13, 2026, 06:59 ET Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis ---- 40.0% of patients achieved SALT-20 response at Week 36 in the mITT analysis and 30.3% of patients achieved SALT-20 response at Week 36 in the ITT analysis of all
More news about: Q32 Bio
Jun 16, 2026, 08:00 ET Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference
Phase 3 registration program.The primary efficacy analysis will be performed using a Modified Intent-To-Treat (mITT) population. This will result in an estimated 450 subjects in the mITT population, randomized in a 1:1 ratio to either ibezapolstat or standard- of-care vancomycin, enrolled into the
More news about: Acurx Pharmaceuticals, Inc.
Jun 12, 2026, 08:00 ET Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight Loss Study in China and Phase II Study in the U.S.
The primary efficacy endpoints were derived from the modified intention-to-treat (mITT) population under the treatment strategy, secondary efficacy endpoints from the mITT population under the hypothetical strategy, and safety endpoints from the safety set (SS) population.Bofanglutide
More news about: Gan & Lee Pharmaceuticals
Jun 10, 2026, 12:15 ET InventHelp Inventor Develops New Mitt for Shortstops (MBQ-770)
/PRNewswire/ -- "I wanted to create a new mitt for shortstops to enhance performance during a game or practice," said an inventor, from Bronx, N.Y., "so I invented THE SHORT STOP MITT. My design would make it easier to hold onto the ball no matter where it hits the mitt."
More news about: InventHelp
May 14, 2026, 07:30 ET Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
or recurrent endometrial cancer. Approximately 220 patients enrolled in the modified intent-to-treat (mITT) population and 257 enrolled in the intent-to-treat (ITT) population. Enrollment in the mITT population was focused on patients with either proficient mismatch repair status (pMMR) tumors or patients
More news about: Karyopharm Therapeutics Inc.
May 04, 2026, 08:00 ET Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
Phase 3 registration program.The primary efficacy analysis will be performed using a Modified Intent-To-Treat (mITT) population. This will result in an estimated 450 subjects in the mITT population, randomized in a 1:1 ratio to either ibezapolstat or standard- of-care vancomycin, enrolled into the
More news about: Acurx Pharmaceuticals, Inc.
Apr 21, 2026, 06:47 ET All the Love for All the Moms: Hallmark's Mother's Day Collection Showcases Lacey Chabert's Spring Designs
oven mitt.Share family recipes as gifts that last for generations. The elegant, hardback
More news about: Hallmark Cards, Inc.
Apr 20, 2026, 07:30 ET 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
[email protected] 52-week analysis, data for week 0-36 in modified intent-to-treat (mITT) adapted population are imputed following primary estimand. The mITT adapted population excludes 4 patients with major study eligibility violations before week 36. These patients did
More news about: Nektar Therapeutics
Mar 31, 2026, 09:36 ET Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
treatment.The above data are derived from the modified Intention-to-treat (mITT) Set and Safety Set (SS) under the treatment policy. Dr. Chen Wei
More news about: Gan & Lee Pharmaceuticals
Mar 30, 2026, 09:00 ET Brown Bee Debuts Its Skincare-First Sunless Glow to the United States
hydrating actives, this lightweight formula delivers a natural-looking tan while providing deep, long-lasting hydration.Self-Tanning Applicator Mitt - Designed with soft microfiber to ensure an even, smooth, streak-free tan while keeping your hands clean. This best-selling accessory makes application
More news about: Brown Bee
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
Hypothetical efficacy estimand in the modified intent-to-treat (mITT) population is used in all endpoints. The hypothetical efficacy estimand represents efficacy in all mITT participants who remained on study intervention without initiating prohibited medication.i
More news about: Eli Lilly and Company
Mar 16, 2026, 09:15 ET Mindy Finn Joins Forward Party as VP, Advancement
leaders who want to serve their communities without being constrained by partisan purity tests.As a strategist for George W. Bush and Mitt Romney, Finn gained firsthand insight into the inner workings of the American political system. Her 2016 campaign for Vice President as an independent
More news about: Forward Party